Annual capacities: 5000 million tablets, 500 million capsules, 5 million powder pro-suspensions
Julphar’s inaugural plant started its commercial manufacturing in 1984 and complies with international standards for finished pharmaceutical manufacturing and cGMP. The Solid Dosage Forms plant specializes in non-sterile solid dosage forms such as tablets, capsules, effervescent tablets and powders for suspensions (PPS) and sachets. This fully automated facility uses the highly sophisticated processes that handles the transfer of raw material through closed systems, without cross contamination. It ensures consistent environmental conditions through intrinsic online, in-process controls and monitoring. Equipment includes fully automated blistering and cartooning machines for final packaging, closed manufacturing systems and well separated technical floors.